Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00132652
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2005-08-18
Brief Title:
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B
Sponsor:
Organization:
Novartis